Skip to main content
Equibles
UFPT logo

UFPT · Ufp Technologies Inc · Metrics

Track UFPT — free

Use UFPT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research UFPT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$311.78 +8.31 (+2.74%) Play latest call Q3 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.35B
Shares
7.75M
Volume · Nov 9 12.76K Avg daily vol (3M) 119.3K

UFPT metrics

104 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$303.47
Market cap
$2.35B

Price action

23 metrics
Price change (1W)
+6.7%
Price change (30D)
+5.0%
Price change (3M)
-3.4%
Price change (6M)
+31.6%
Price change (YTD)
+36.7%
Price change (1Y)
+36.2%
Trailing year
Price change (5Y)
+360.6%
52-week high
$334.84
52-week low
$185.45
Change from 52-week high
-9.4%
Change from 52-week low
+63.6%
Annualized volatility
51.0%
Annualized volatility (3M)
46.7%
Implied volatility (30D)
51.5%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.6
RSI (14D)
53.9
Price vs SMA 50
+4.2%
Price vs SMA 200
+21.3%
Avg volume (3M)
119,295
Relative volume
0.9
Average dollar volume
$35.58M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
7.75M

Valuation

12 metrics
P / E (TTM)
30.9
Trailing earnings · reciprocal yield 3.2%
PEG ratio
1.2
EV / revenue
3.7×
reciprocal yield 26.8%
EV / EBITDA
22.2×
reciprocal yield 4.5%
EV / EBIT
24.1×
reciprocal yield 4.1%
P / sales
3.6×
reciprocal yield 27.6%
P / book
4.8
reciprocal yield 20.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
31.7
reciprocal yield 3.2%
Earnings yield
3.3%

Historical valuation

8 metrics
P / E historical average (3Y)
32.6×
reciprocal yield 3.1%
P / E historical average (5Y)
30.6×
reciprocal yield 3.3%
EV / revenue historical average (3Y)
3.9×
reciprocal yield 25.5%
EV / revenue historical average (5Y)
3.6×
reciprocal yield 28.1%
EV / EBIT historical average (3Y)
25.7×
reciprocal yield 3.9%
EV / EBIT historical average (5Y)
24.4×
reciprocal yield 4.1%
EV / EBITDA historical average (3Y)
21.7×
reciprocal yield 4.6%
EV / EBITDA historical average (5Y)
19.6×
reciprocal yield 5.1%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-04

Profitability

9 metrics
Gross margin
28.9%
Operating margin
15.5%
Trailing 12 months
Net margin
11.8%
Gross profit (TTM)
$188.01M
Operating profit (TTM)
$100.58M
Net income (TTM)
$76.53M
Trailing 12 months
Diluted EPS (TTM)
$9.81
FCF margin
—
Effective tax rate
18.3%

Per share

11 metrics
Revenue per diluted share (TTM)
$83.08
Gross profit per diluted share (TTM)
$24.05
Operating profit per diluted share (TTM)
$12.87
EBITDA per diluted share (TTM)
$14.43
Net income per diluted share (TTM)
$9.79
Operating cash flow per diluted share (TTM)
$9.49
Free cash flow per diluted share (TTM)
$9.30
Capital expenditures per diluted share (TTM)
$1.39
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$1.43
Book value per share
$54.95

Growth

11 metrics
Revenue growth YoY
+11.6%
Year over year
Net income growth YoY
+25.8%
Revenue (TTM)
$649.51M
Trailing 12 months
EPS growth YoY
+25.1%
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
+19.4%
Revenue CAGR (5Y)
+27.4%
EPS CAGR (3Y)
+17.1%
EPS CAGR (5Y)
+37.7%
FCF CAGR (3Y)
+85.7%
FCF CAGR (5Y)
+17.5%

Quality

14 metrics
Return on equity
15.8%
Return on assets
11.2%
Debt / equity
0.2
Current ratio
3.0
EBITDA (TTM)
$112.51M
Free cash flow (TTM)
—
Quick ratio
1.7
Interest coverage
14.6
Net debt / EBITDA
1.3
Return on invested capital
14.6%
Trailing 12 months
Net cash
−$75.38M
Latest balance sheet
Cash & equivalents
$20.62M
Total assets
$682.63M
Total debt
$96.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$74.20M
Capital expenditures (TTM)
$10.83M
R&D (TTM)
—
SG&A (TTM)
$87.89M
Stock compensation (TTM)
$11.14M
R&D / revenue
—
Stock compensation / revenue
1.7%

Ownership (13F)

9 metrics
13F filers
283
13F filer change QoQ
+7
Institutional ownership
123.0%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+12.0%
Holder tenure
15.0
Price vs estimated holder cost
+25.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
24.1%

Short interest

3 metrics
Short interest
12.7%
Latest settlement · 8.7 days to cover
Days to cover
8.7d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.18M
Insider-sentiment score
14 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 914156 CUSIP 902673102 13F (30d) 167 filings 137 filers Visit website Investor relations